Detalhe da pesquisa
1.
IFN-γ+ CD4+T cell-driven prophylactic potential of recombinant LDBPK_252400 hypothetical protein of Leishmania donovani against visceral leishmaniasis.
Cell Immunol
; 361: 104272, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33445051
2.
In silico study indicates antimalarials as direct inhibitors of SARS-CoV-2-RNA dependent RNA polymerase.
J Biomol Struct Dyn
; 40(12): 5588-5605, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33475021
3.
Nanodiagnostics in leishmaniasis: A new frontiers for early elimination.
Wiley Interdiscip Rev Nanomed Nanobiotechnol
; 13(2): e1675, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33142369
4.
Assessing L. donovani Skin Parasite Load: A Proof of Concept Study of a Microbiopsy Device in an Indian Setting.
Front Cell Infect Microbiol
; 11: 645121, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33791246
5.
Effect of Arsenic Stress on Expression Pattern of a Rice Specific miR156j at Various Developmental Stages and Their Allied Co-expression Target Networks.
Front Plant Sci
; 11: 752, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32612618
6.
Modified solid lipid nanoparticles encapsulated with Amphotericin B and Paromomycin: an effective oral combination against experimental murine visceral leishmaniasis.
Sci Rep
; 10(1): 12243, 2020 07 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-32699361
7.
Post kala-azar dermal leishmaniasis: A threat to elimination program.
PLoS Negl Trop Dis
; 14(7): e0008221, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32614818
8.
Evaluation of Safety and Antileishmanial Efficacy of Amine Functionalized Carbon-Based Composite Nanoparticle Appended With Amphotericin B: An in vitro and Preclinical Study.
Front Chem
; 8: 510, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32719770
9.
Epigenetic Aspects of Engineered Nanomaterials: Is the Collateral Damage Inevitable?
Front Bioeng Biotechnol
; 7: 228, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31616663
10.
Envisioning the innovations in nanomedicine to combat visceral leishmaniasis: for future theranostic application.
Nanomedicine (Lond)
; 14(14): 1911-1927, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31313971
11.
Limitations of Current Therapeutic Options, Possible Drug Targets and Scope of Natural Products in Control of Leishmaniasis.
Mini Rev Med Chem
; 18(1): 26-41, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-28443518
12.
Centrin-Deleted Leishmania donovani Parasites Help CD4+ T Cells to Acquire Th1 Phenotype and Multi-Functionality Through Downregulation of CD200-CD200R Immune Inhibitory Axis.
Front Immunol
; 9: 1176, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29915577
13.
Leishmania donovani infection activates Toll-like receptor 2, 4 expressions and Transforming growth factor-beta mediated apoptosis in renal tissues.
Braz J Infect Dis
; 21(5): 545-549, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28606413
14.
Solute carrier protein family 11 member 1 (Slc11a1) activation efficiently inhibits Leishmania donovani survival in host macrophages.
J Parasit Dis
; 41(3): 671-677, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28848257
15.
Identification and Characterization of miRNAs in Response to Leishmania donovani Infection: Delineation of Their Roles in Macrophage Dysfunction.
Front Microbiol
; 8: 314, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28303124
16.
Corrigendum: Identification and Characterization of miRNAs in Response to Leishmania donovani Infection: Delineation of Their Roles in Macrophage Dysfunction.
Front Microbiol
; 8: 1190, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28659911
17.
Leishmania donovani infection activates Toll-like receptor 2, 4 expressions and Transforming growth factor-beta mediated apoptosis in renal tissues
Braz. j. infect. dis
; 21(5): 545-549, Sept.-Oct. 2017. graf
Artigo
em Inglês
| LILACS | ID: biblio-1039201